Cargando…

Cluster‐randomized trial to improve the quality of diabetes management: The study for the efficacy assessment of the standard diabetes manual (SEAS‐DM)

AIMS/INTRODUCTION: ‘The Standard Diabetes Manual’ has been developed by clinical researchers from multiple major institutions in Japan, such as the National Center for Global Health and Medicine, as a comprehensive disease management program, including collaboration between primary care physicians (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noto, Hiroshi, Tanizawa, Yukio, Aizawa, Toru, Sone, Hirohito, Yoshioka, Narihito, Terauchi, Yasuo, Inagaki, Nobuya, Noda, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931204/ https://www.ncbi.nlm.nih.gov/pubmed/27181755 http://dx.doi.org/10.1111/jdi.12455

Ejemplares similares

Japanese Clinical Practice Guideline for Diabetes 2019
por: Araki, Eiichi, et al.
Publicado: (2020)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes
por: Goto, Atsushi, et al.
Publicado: (2016)

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus
por: Nakamura, Jiro, et al.
Publicado: (2017)

Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age
por: Hayashi, Toshio, et al.
Publicado: (2013)

Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study
por: Goto, Atsushi, et al.
Publicado: (2012)

Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial
por: Kaku, Kohei, et al.
Publicado: (2019)

Latest insights into the risk of cancer in diabetes
por: Noto, Hiroshi, et al.
Publicado: (2013)

Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
por: Noto, Hiroshi, et al.
Publicado: (2013)

Significantly increased risk of cancer in diabetes mellitus patients: A meta‐analysis of epidemiological evidence in Asians and non‐Asians
por: Noto, Hiroshi, et al.
Publicado: (2011)

Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
por: Noto, Hiroshi, et al.
Publicado: (2012)

Protocol for a large-scale prospective observational study with alogliptin in patients with type 2 diabetes: J-BRAND Registry
por: Inagaki, Nobuya, et al.
Publicado: (2014)

Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
por: Yabe, Daisuke, et al.
Publicado: (2022)

Dietary salt intake and diabetes complications in patients with diabetes: An overview
por: Horikawa, Chika, et al.
Publicado: (2017)

Is the Proportion of Carbohydrate Intake Associated with the Incidence of Diabetes Complications?—An Analysis of the Japan Diabetes Complications Study
por: Horikawa, Chika, et al.
Publicado: (2017)

Oral Glucose Tolerance Testing identifies HIV+ infected women with Diabetes Mellitus (DM) not captured by standard DM definition
por: Seang, Sophie, et al.
Publicado: (2016)

Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study
por: Araki, Eiichi, et al.
Publicado: (2019)

Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases
por: Inoue, Kaori, et al.
Publicado: (2015)

Dietary intake in Japanese patients with type 2 diabetes: Analysis from Japan Diabetes Complications Study
por: Horikawa, Chika, et al.
Publicado: (2013)

Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
por: Moriya, Tatsumi, et al.
Publicado: (2013)

Randomized controlled trial of single‐agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study
por: Shihara, Nobuyuki, et al.
Publicado: (2011)

Intakes of Dietary Fiber, Vegetables, and Fruits and Incidence of Cardiovascular Disease in Japanese Patients With Type 2 Diabetes
por: Tanaka, Shiro, et al.
Publicado: (2013)

Recent updates in factors associated with incidence and screening of diabetic eye disease
por: Sone, Hirohito
Publicado: (2023)

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020)

Circadian rhythms and diabetes
por: Kurose, Takeshi, et al.
Publicado: (2011)

Seasonal Variations of Severe Hypoglycemia in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and Non-diabetes Mellitus: Clinical Analysis of 578 Hypoglycemia Cases
por: Tsujimoto, Tetsuro, et al.
Publicado: (2014)

Japanese Clinical Practice Guideline for Diabetes 2016
por: Haneda, Masakazu, et al.
Publicado: (2018)

The diet in children with diabetes mellitus (DM)
por: Iafusco, Dario, et al.
Publicado: (2014)

Molecular biomarkers in diabetes mellitus (DM)
por: Aghaei Zarch, Seyed Mohsen, et al.
Publicado: (2020)

Predicting Macro- and Microvascular Complications in Type 2 Diabetes: The Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine
por: Tanaka, Shiro, et al.
Publicado: (2013)

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
por: Fujihara, Kazuya, et al.
Publicado: (2018)

Machine Learning Approach to Drug Treatment Strategy for Diabetes Care
por: Fujihara, Kazuya, et al.
Publicado: (2023)

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
por: Kaku, Kohei, et al.
Publicado: (2014)

Targeting β‐cell functions in therapy for type 2 diabetes
por: Fujimoto, Shimpei, et al.
Publicado: (2011)

Association between Low Protein Intake and Mortality in Patients with Type 2 Diabetes
por: Yamaoka, Takuya, et al.
Publicado: (2020)

Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study
por: Inagaki, Nobuya, et al.
Publicado: (2015)

Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: A report from Collaborative Initiative by six Japanese Associations
por: Nakashima, Naoki, et al.
Publicado: (2019)

Impact of population aging on trends in diabetes prevalence: A meta-regression analysis of 160,000 Japanese adults
por: Charvat, Hadrien, et al.
Publicado: (2015)

Control of intestinal stem cell fate: A novel approach to treating diabetes
por: Yamane, Shunsuke, et al.
Publicado: (2015)

Diabetes care: After the Great East Japan Earthquake
por: Kishimoto, Miyako, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_itn6qsdf6e4iq4b5rnqk583ruh